血骨形态遗传蛋白9和急性缺血性中风后的主要心血管事件和死亡率:一个前性的多中心研究
Ruirui Wang1, Yi Chen2, Xiangyan Yin2
1Department of Epidemiology, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China; Jiangsu Key Laboratory of Preventive and Translational Medicine for Major Chronic Non-communicable Diseases, Suzhou Medical College of Soochow University, Suzhou, China.
Nutrition, metabolism, and cardiovascular diseases : NMCD
|February 18, 2026
概括
血液中骨形态蛋白9 (BMP9) 的较高水平与急性缺血性中风后不良结果的风险较低有关. 这表明BMP9可能是中风和心血管并发症的潜在治疗标.
科学领域:
- 生物医学研究的研究.
- 心血管科学 心血管科学
- 神经学 神经学
背景情况:
- 骨形态遗传蛋白9 (BMP9) 在内皮保护和血管发育中起作用.
- 在急性缺血性中风后,循环BMP9水平与临床结果之间的关联尚未得到充分理解.
研究的目的:
- 调查急性缺血性中风患者的血BMP9水平和临床结果之间的关系.
主要方法:
- 一项多中心前性研究,涉及3400名缺血性中风患者.
- 测量了血中的BMP9水平.
- 临床结果包括心血管事件,复发性中风和全因死亡率在3个月内被跟踪.
- 使用考克斯回归模型分析了BMP9水平与结果之间的关联.
主要成果:
- 血BMP9水平的增加与心血管事件,复发性中风和全因死亡率显著降低的风险有关.
- 与BMP9最高三位数的参与者相比,与最低三位数的参与者相比,不良结果的风险要低得多.
- 将BMP9添加到风险模型中,改善了患者结局的重新分类.
结论:
- 血BMP9水平升高与急性缺血性中风后不良临床结果风险降低有关.
- BMP9信号通路显示为治疗缺血性中风和相关心血管并发症的治疗点.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
947
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
947
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
625
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
625
Ischemic Heart Disease: Overview
3.5K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K


